Adrenaline

Running

Cycling

Overseas

Skydiving

1 January 2024 - 31 December 2025

Skydiving

Take on a skydive for blood cancer patients! If you're a budding thrill seeker, an adrenaline junkie or simply want to experience something incredible, a charity skydive could be for you.

1 January 2024 - 31 December 2025

Tell us about another event

Taking on an event for Leukaemia Care and its not listed here? Tell us about it

1 January 2024 - 31 December 2025

Zipwire

Take on the thrilling experience of flying at 100 miles per hour - all while raising money for us to support blood cancer patients

1 January 2024 - 31 December 2025

Bungee jump

Take the plunge for Leukaemia Care at various venues across the UK

1 January 2025 - 31 December 2025

Adrenaline Challenges

Feel the thrill whilst fundraising for those living with Leukaemia by taking on one of our adrenaline challenges!

10 May 2025 - 21 September 2025

Tough Mudder Events 2025

The ultimate obstacle course challenge now has multiple obstacles over a 5 to 15 Kilometre run. Take on the challenge at a local of your choice in 2025,

Useful links on exercise

Returning to a “normal” life can see you reintroducing exercise into your daily routine. The following links contain excellent resources about exercise during and post treatment for a blood cancer.

Take a Moment to Catch Up

View our latest news and blog articles

November 11th

Additional treatment for AML patients now available in Scotland

Leukaemia Care is pleased to announce that newly diagnosed acute myeloid leukaemia (AML) patients with a FLT3 mutation now have access to quizartinib, in combination with chemotherapy, thanks to a decision made by the Scottish Medicines Consortium (SMC) today. ...

October 31st

Leukaemia Care’s response to the 2024 Autumn Budget

"We welcome the increase in the NHS budget. However..." - Colin Dyer, Chief Executive at Leukaemia Care shares the charity's response....

October 22nd

NEW NHS treatment option for myelofibrosis patients

Certain patients with myelofibrosis will have access to fedratinib to treat myelofibrosis, thanks to a decision made by the National Institute for Health and Care Excellence (NICE). ...